These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35165712)

  • 1. Tackling postoperative sudden cardiac death in high-risk cardiac surgical patients-role of wearable cardioverter defibrillators.
    Starck C; Kaemmel J; Falk V
    Eur J Cardiothorac Surg; 2022 May; 61(5):1041-1042. PubMed ID: 35165712
    [No Abstract]   [Full Text] [Related]  

  • 2. Underdetection of Ventricular Fibrillation by Wearable Cardioverter-Defibrillator Leading to Sudden Death.
    Kokubun H; Miyauchi Y; Inada S; Shimizu W
    Circ J; 2020 Dec; 85(1):79. PubMed ID: 33208580
    [No Abstract]   [Full Text] [Related]  

  • 3. [The wearable cardioverter defibrillator].
    Aich R; Tridetti J; Pirlet C; Barbraud C; Melissopoulou M; Troisfontaines P
    Rev Med Liege; 2022 Oct; 77(10):557-564. PubMed ID: 36226391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of paced ECGs by the wearable defibrillator : Pitfalls and solutions].
    Zylla MM; Thomas D
    Herzschrittmacherther Elektrophysiol; 2021 Dec; 32(4):500-503. PubMed ID: 34713343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
    Israel C; Staudacher I; Leclercq C; Botto GL; Scherr D; Fach A; Duru F; Zylla MM; Katus HA; Thomas D
    Clin Res Cardiol; 2022 Nov; 111(11):1189-1197. PubMed ID: 35305126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.
    Viani S; Soldati E; DI Cori A; Segreti L; Paperini L; DE Lucia R; Zucchelli G; Bongiorni MG
    Minerva Cardioangiol; 2018 Feb; 66(1):83-99. PubMed ID: 28696089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wearable cardioverter-defibrillators after myocardial infarction: a review of its clinical utility and unmet needs in current clinical practice.
    Hioki H; Kozuma K; Kobayashi Y; Ando K; Morino Y; Kishihara J; Ako J; Ikari Y
    Cardiovasc Interv Ther; 2022 Jan; 37(1):53-59. PubMed ID: 34195951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcome of wearable cardioverter-defibrillator therapy stratified by gender: Insights from a multicenter international registry.
    Abumayyaleh M; Koepsel K; Aweimer A; Ewers A; Erath JW; Kuntz T; Klein N; Kovacs B; Duru F; Saguner AM; Blockhaus C; Shin DI; Gotzmann M; Lapp H; Beiert T; Mügge A; El-Battrawy I; Akin I
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1502-1505. PubMed ID: 37051873
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator : Different viewpoints around the world.
    Cooper M; Berent T; Auer J; Berent R
    Wien Klin Wochenschr; 2020 Dec; 132(23-24):770-781. PubMed ID: 32435868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The wearable cardiac defibrillator: the meeting point between the latest scientific evidence and clinical applicability].
    Arena G; Casolo G; Giaccardi M
    G Ital Cardiol (Rome); 2021 Sep; 22(9):742-750. PubMed ID: 34463683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who Should Receive a Wearable Defibrillator Vest at Hospital Discharge?
    Kachur S; Morin DP
    Curr Cardiol Rep; 2019 Sep; 21(10):125. PubMed ID: 31494744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The wearable cardioverter defibrillator - temporary protection against sudden cardiac death].
    Almqvist M; Mattsson G; Magnusson P
    Lakartidningen; 2019 Apr; 116():. PubMed ID: 31192401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we need the wearable cardioverter-defibrillator (WCD)?
    Klein HU
    Int J Cardiol; 2018 Oct; 268():151-152. PubMed ID: 30041781
    [No Abstract]   [Full Text] [Related]  

  • 16. Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease.
    Elayi CS; Erath-Honold JW; Jabbari R; Roubille F; Silvain J; Barra S; Providencia R; Njeim M; Narayanan K; Deharo JC; Defaye P; Boveda S; Leclercq C; Marijon E
    Europace; 2020 Oct; 22(10):1600. PubMed ID: 32163138
    [No Abstract]   [Full Text] [Related]  

  • 17. Keeping up to date: a current review of wearable cardioverter defibrillator use.
    Ashraf S; Ilyas S; Siddiqui F; Ando T; Shokr M; Panaich S; Briasoulis A; Afonso L; Khan M
    Acta Cardiol; 2020 Dec; 75(8):695-704. PubMed ID: 31687917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The wearable cardioverter-defibrillator-Improving comfort and reaching towards noise immunity.
    Varma N
    J Cardiovasc Electrophysiol; 2022 May; 33(5):843-844. PubMed ID: 35175650
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.